Pendapatan dodolan perusahaan amneal.com (AMRX)

amneal.com - logo grafis emiten AMRX

The reliability of Amneal Pharmaceuticals (AMRX) guarantees stable demand for affordable medications regardless of economic conditions. The company's current sales levels confirm this resilience, where the value of 3.20 characterizes this level. The business's defensive status minimizes the impact of crises, while diversification between biosimilars and neurology effectively offsets pricing risks, creating a balanced revenue stream.

Amneal Pharmaceuticals (AMRX): Pendapatan perusahaan saka 04.07.2022 nganti 18.11.2026

Rincian metrik komprehensif lan analitis amneal.com (AMRX)

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:AMRX, amneal.com
Sampel barang Amneal Pharmaceuticals

Amneal Pharmaceuticals' exit from generic stagnation and the launch of complex biosimilars directly determine the upward trajectory of the company's execution history. This indicator captures the average daily cash inflow, transforming total revenue into a precise capital inflow rate, which allows investors to assess the business's real momentum and the fundamental stability of the asset's market capitalization.

Analisis perusahaan pesaing

HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|Perrigo Company PLC - Pendapatan lan volume dodolan|ALVO: Pendapatan perusahaan|liquidia.com (LQDA) - Pendapatan perusahaan|GLPG (Galapagos) - Pendapatan perusahaan|Dodolan perusahaan ANIP|Volume dodolan perusahaan MNKD (Afrezza)|Pendapatan lan volume dodolan AMPH|PCRX (Pacira BioSciences) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Pendapatan perusahaan|Aquestive Corp - Pendapatan lan volume dodolan|scpharmaceuticals.com (SCPH) - Dodolan perusahaan|TECX: Pendapatan lan volume dodolan|Tonix Pharmaceuticals - Pendapatan dodolan perusahaan|Dodolan perusahaan SXTC|EPRX: Pendapatan dodolan perusahaan|Dodolan perusahaan BHST (BioHarvest Sciences Inc.)|Pendapatan reged perusahaan Invizyne|Pendapatan perusahaan Oramed Pharmaceuticals ORMP|Pendapatan dodolan perusahaan ENTX|HYFT - Pendapatan perusahaan|Pendapatan dodolan perusahaan ABVC (ABVC BioPharma Inc.)|CPIX: Pendapatan lan volume dodolan|Quantum BioPharma Limited - Pendapatan dodolan perusahaan|FGEN (FibroGen Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Telomir Pharmaceuticals|Pendapatan lan volume dodolan RANI|SNYR (Synergy CHC Corp.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLYB (Rallybio Corp)|LEXX: Volume dodolan perusahaan|PULM - Pendapatan perusahaan|PTHL: Pendapatan perusahaan|APM (aptorumgroup.com) - Dodolan perusahaan|Lyra Therapeutics - Pendapatan dodolan perusahaan|Pendapatan perusahaan Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan YCBD|PRFX: Pendapatan tahunan perusahaan|Pendapatan perusahaan altamiratherapeutics.com CYTO|Pendapatan lan volume dodolan Lipella Pharmaceuticals Inc LIPO|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP